Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUMO1 pseudogene 1 (SUMO1P1, also known as SUMO5) is a human **pseudogene**, previously classified as a protein-coding gene in early literature, but not recognized as a canonical protein-coding gene in major databases. While SUMO5 in earlier studies was suggested to encode a functional small ubiquitin-like modifier in primates with some unique sumoylation events, later data and current genome curation agree it is a **non-functional pseudogene** in humans[3]. Its best-characterized protein-coding paralogs are SUMO1, SUMO2, and SUMO3, which encode proteins that post-translationally modify substrates, regulating transcription, cell cycle events, and nuclear body organization[2][4]. SUMO1P1 is not considered a therapeutic target, has no known directly associated drugs, and does not have independent biological or disease roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small ubiquitin-related modifier 5 (SUMO5 (sometimes SUMO1P1)).